Background and purpose It remains inconclusive whether asymptomatic intracranial
hemorrhage (aICH) after acute ischemic stroke is innocuous. We aimed to conduct a meta …

Introduction It is unknown whether alteplase is effective and safe in patients with mild acute
ischemic stroke (AIS). Determining whether symptoms are “disabling” or not is a crucial …

Intravenous thrombolysis (IVT) in patients with a low National Institutes of Health Stroke
Scale (NIHSS) score of 0–5 remains controversial. IVT should be used in patients with mild …

Background The safety and efficacy of intravenous thrombolysis (IVT) in acute ischemic
stroke patients with large vessel occlusions and mild neurological deficits are controversial …

Background and Purpose: The role of intravenous thrombolysis in patients with acute mild
ischemic stroke remains highly controversial. Therefore, this study aims to analyze the …

Фармакологический тромболизис широко применяется для ликвидации
жизнеугрожающих тромбозов. Эта медицинская технология постоянно …

目的探讨静脉溶栓时间对急性轻型脑梗死和短暂性脑缺血发作患者早期认知功能的影响.
方法收集2017 年1 月—2019 年12 月就诊于温州医科大学附属第一医院急性轻型脑梗死和短暂 …

Objective: Mild stroke is used to describe patients with stroke having a National Institutes of
Health Stroke Scale (NIHSS) score of 0-6. However, there is still no clear decision regarding …

Background: Intravenous thrombolysis is the preferred clinical treatment for ultra-early (< 4.5
h) ischemic stroke. However, whether intravenous thrombolysis should be used in patients …

Stroke is one of the main causes of mortality and disability in developed countries. In acute
ischemic stroke, the standard treatment is recombinant tissue plasminogen activator (rt-PA) …